RPS6 and prostate carcinoma: Hsieh et al. reported that INK128 completely restored phosphorylation of the 4E-BP1/eIF4E and p70S6K/RPS6 axes in a prostate cancer preclinical study 45, which means that INK128 may have effects in HCC.